Equol-producing lactic acid bacteria-containing composition
CA 2531173 C · Owner: Otsuka Pharmaceutical Co. Ltd. · Inventors: Uchiyama, Shigeto; Suzuki, Toshimi; Ueno, Tomomi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides an equol-producing lactic acid bacteria-containing composition comprising as an essential , component thereof, a lactic acid bacterial strain belonging to the genus Lactococcus having an ability to utilize at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein to produce equol. Such a composition is effective for the prevention and alleviation of malaise inclusive of climacteric disturbance in middle-aged and elderly women for which no effective prophylactic method or alleviating means has heretofore been available.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 29, 2004 and granted September 10, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 29, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 29, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.